Second, upregulation of PSPC1 and IGF1R as well as their downstream signaling are known to activate epithelial to mesenchymal transition (EMT), stemness, and metastasis in association with poor prognosis of cancer patients [11,42,43,44]. This evidence concerns the gene IGF1R and cancer.